Clinical trial Recruiting at 1 site Interventional Ages 5 to 21

Using a humanoid robot and virtual reality games to help children with cerebral palsy improve arm function

Official title: Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial

Run by Georgia State University · NCT06881407 · Data updated 2026-11-12

This study is testing if a fun system using a robot and virtual reality games can help kids with cerebral palsy improve their arm movement at home.

Quick facts

Study typeInterventional
Ages5 Years to 21 Years
SexAll
Enrollment42 (estimated)
SponsorGeorgia State University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedFebruary 25, 2025
Main results expectedAugust 31, 2027
Study endsAugust 31, 2028
Registry record updatedAugust 20, 2026
Trial IDNCT06881407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 5 to 21 years diagnosed with spastic cerebral palsy who have a manual ability classification system level of I-III.

Probably not a fit

Patients who have had recent surgery or botulinum toxin injections in the training arm, or those with severe attention deficits or uncontrolled epilepsy, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to enhance arm function in children with cerebral palsy (CP) through a home-based intervention using a humanoid robot combined with virtual reality games. The THRIVE system is designed to provide a motivating and tailored upper-extremity exercise program that encourages children to engage in repetitive movements necessary for improvement. By utilizing instant feedback and interactive play, the system seeks to increase compliance and motivation for home exercises. The study will evaluate the effectiveness of this innovative approach in improving arm function among participants aged 5 to 21 years with spastic CP.

Why it matters

Potential benefit: If successful, this intervention could significantly improve arm function and overall quality of life for children with cerebral palsy.

How similar studies have gone: While the use of robotic and virtual reality interventions in rehabilitation is gaining traction, this specific combination for children with cerebral palsy is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants are between the ages of 5 and 21 years;
2. diagnosed with spastic CP;
3. have a manual ability classification system (MACs) level I-III;
4. able to sit with trunk supported;
5. are able to reach forward for more than half of their arm length;
6. are able to comprehend and complete a three-steps commands;
7. are able to see a TV screen (with or without corrected vision); and
8. their primary caregiver is willing to follow the desired intervention dosing and all evaluation measurements.

Exclusion Criteria:

1. they have received surgery or botulinum toxin type A injection in the training arm within the preceding 4 months or are scheduled to receive it during the planned intervention period, or
2. if they have a severe attention deficit or uncontrolled epilepsy, which may possibly be triggered by the light or sound of the video games.

Where it's running

  • Department of Physical Therapy, Georgia State University
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.